Clinical trial · Interventional
Clinical Study Between Robotic and Open Surgery in Patients With Pancreatic Cancer
Prospective Cohort Study Comparing Robotic and Open Surgery for Pancreatic Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine whether robotic surgery has limitations in terms of patient age, tumor size, location, and vascular relationship when compared to open surgery for pancreatic cancer. Whether robotic surgery has advantages over intraoperative bleeding, operative time, postoperative complications (bleeding, infection, pancreatic fistula) and postoperative hospital stays compared to open surgery.And the differences in lymph nodes harvest and postoperative survival between two groups.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Minimally Invasive Surgery | — | UNRESOLVED | — |
| Pancreatic Ductal Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| open surgery | Procedure | — | UNRESOLVED |
| robotic surgery | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- robotic pancreatectomy
- description
- robotic pancreatectomy(including pancreaticoduodenectomy and distal pancreatectomy)
- interventionNames
- Procedure: robotic surgery
- type
- ACTIVE_COMPARATOR
- label
- open surgery
- description
- open pancreatectomy(including pancreaticoduodenectomy and distal pancreatectomy)
- interventionNames
- Procedure: open surgery
Primary outcomes (2)
- measure
- 1 year overall survival rate
- timeFrame
- 1 year post-operation
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnosed pancreatic ductal adenocarcinoma * Patients and their families volunteered to test and signed informed consent. Exclusion Criteria: * Preoperative exclusion: 1. Patients with metastasis (M1) 2. Patients with tumor recurrence 3. Patients with artery and/or vein invasion and can't perform radical resection and reconstruction 4. Patients with poor cardiopulmonary function cannot tolerate surgery; 5. receive neoadjuvant radiotherapy and chemotherapy before surgery; 6. The patient or family member refuses to join the group; 7. Pregnant patients * Intraoperative exclusion: 1. Intraoperative exploration of metastases in other parts besides the primary lesion 2. Other organs malignant tumors metastasize to the pancreas * Postoperative exclusion: 1. pathology confirmed non-pancreatic ductal adenocarcinoma
References
Publications (0)
Data not yet available